menu
    • menu

    Company profile for Mezzion Pharma Co Ltd

    NEW Drugs in Dev: 1
    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Mezzion Inc. is a company specialized in global new drug development process that generates profit through identifying new candidate drugs, developing the new drug up to a certain level in clinical trials (generally up to phase 2 and licensing-out to a suitable partner, operating based on a new business model with profits from up-front payment, milestone payment, and royalty.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Mezzion Pharma Co Ltdkorearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    7F, Seokcheon Building, 570 Samseong?ro, Seoul 06163
    Telephone
    Telephone
    02-560-8008
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.mezzion.co.kr/eng/index.asp
    Linkedin
    Linkedin
    https://in.linkedin.com/company/mezzion-pharma-co-ltd
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    IMCAS Asia

    IMCAS Asia

    Not Confirmed

    envelop Contact Supplier

    IMCAS Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Mezzion Pharma Clears FUEL-2 Phase 3 Regulatory Milestone
    Mezzion Pharma Clears FUEL-2 Phase 3 Regulatory Milestone

    05 Jun 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mezzion-pharma-completes-fuel-2-phase-3-regulatory-milestone-302792125.html

    PR NEWSWIRE
    05 Jun 2026
    Share Share
    Mezzion Secures Financing to Advance Phase 3 FUEL-2 Trial
    Mezzion Secures Financing to Advance Phase 3 FUEL-2 Trial

    14 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mezzion-secures-strategic-financing-to-support-advancement-of-global-phase-3-fuel-2-trial-in-fontan-patients-302772210.html

    PR NEWSWIRE
    14 May 2026
    Share Share
    Mezzion Gets Pre-IND FDA Feedback on Udenafil in ADPKD
    Mezzion Gets Pre-IND FDA Feedback on Udenafil in ADPKD

    07 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mezzion-reports-pre-ind-fda-feedback-on-the-development-of-udenafil-in-adpkd-302765688.html

    PR NEWSWIRE
    07 May 2026
    Share Share
    Mezzion Pharma Applauds Give Kids A Chance Act Enactment
    Mezzion Pharma Applauds Give Kids A Chance Act Enactment

    04 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mezzion-pharmaceuticals-applauds-give-kids-a-chance-act-becoming-law-302678791.html

    PR NEWSWIRE
    04 Feb 2026
    Share Share
    Mezzion Pharma Names Ridwan Shabsigh As FACS President & COO
    Mezzion Pharma Names Ridwan Shabsigh As FACS President & COO

    06 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mezzion-pharmaceuticals-appoints-physician-scientist-ridwan-shabsigh-md-facs-as-president--chief-operating-officer-302653786.html

    PR NEWSWIRE
    06 Jan 2026
    Share Share
    Mezzion Bolsters Udenafil Exclusivity In Fontan Patients
    Mezzion Bolsters Udenafil Exclusivity In Fontan Patients

    03 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mezzion-announces-us-patent-allowance-strengthening-udenafil-exclusivity-in-fontan-patients-302631809.html

    PR NEWSWIRE
    03 Dec 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search